Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuko Y Palesch

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Frontiers of Neurology and Neuroscience|May 30, 2009
Design and analysis plansYuko Y Palesch
Stroke|November 8, 2014
Some common misperceptions about P valuesYuko Y Palesch
Stroke|December 1, 2007
Comments regarding the recent OAST articleScott W Miller, Yuko Y Palesch
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|October 30, 2004
An efficient multi-stage, single-arm Phase II futility design for ALSYuko Y Palesch, Barbara C Tilley
Statistical Methods in Medical Research|January 15, 2015
A surrogate-primary replacement algorithm for response-adaptive randomization in stroke clinical trialsAmy S Nowacki, Wenle Zhao, Yuko Y Palesch
Stroke|December 31, 2015
The National Institutes of Health StrokeNet: A User's GuideJoseph P Broderick, Yuko Y Palesch, L Scott Janis, et al.
The New England Journal of Medicine|June 21, 2013
Endovascular treatment for acute ischemic strokeJoseph P Broderick, Thomas A Tomsick, Yuko Y Palesch
The New England Journal of Medicine|December 14, 2016
Intensive Blood-Pressure Lowering in Cerebral HemorrhageAdnan I Qureshi, Yuko Y Palesch, Jose I Suarez
Journal of Biopharmaceutical Statistics|May 27, 2015
Assessing the impact of safety monitoring on the efficacy analysis in large Phase III group sequential trials with non-trivial safety event rateYanqiu Weng, Yuko Y Palesch, Stacia M DeSantis, et al.
Neurocritical Care|August 15, 2013
High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methodsSharon D Yeatts, Yuko Y Palesch, Claudia S Moy, et al.
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Frontiers of Neurology and Neuroscience|May 30, 2009
Design and analysis plansYuko Y Palesch
Stroke|November 8, 2014
Some common misperceptions about P valuesYuko Y Palesch
Stroke|December 1, 2007
Comments regarding the recent OAST articleScott W Miller, Yuko Y Palesch
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|October 30, 2004
An efficient multi-stage, single-arm Phase II futility design for ALSYuko Y Palesch, Barbara C Tilley
Statistical Methods in Medical Research|January 15, 2015
A surrogate-primary replacement algorithm for response-adaptive randomization in stroke clinical trialsAmy S Nowacki, Wenle Zhao, Yuko Y Palesch
Stroke|December 31, 2015
The National Institutes of Health StrokeNet: A User's GuideJoseph P Broderick, Yuko Y Palesch, L Scott Janis, et al.
The New England Journal of Medicine|June 21, 2013
Endovascular treatment for acute ischemic strokeJoseph P Broderick, Thomas A Tomsick, Yuko Y Palesch
The New England Journal of Medicine|December 14, 2016
Intensive Blood-Pressure Lowering in Cerebral HemorrhageAdnan I Qureshi, Yuko Y Palesch, Jose I Suarez
Journal of Biopharmaceutical Statistics|May 27, 2015
Assessing the impact of safety monitoring on the efficacy analysis in large Phase III group sequential trials with non-trivial safety event rateYanqiu Weng, Yuko Y Palesch, Stacia M DeSantis, et al.
Neurocritical Care|August 15, 2013
High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methodsSharon D Yeatts, Yuko Y Palesch, Claudia S Moy, et al.
Pageof 9